课题基金 / 基金详情

BME: DNA Origami for Investigating and Reprogramming Cell Signaling

BME: DNA Origami for Investigating and Reprogramming Cell Signaling
BME:用于研究和重编程细胞信号转导的 DNA 折纸
批准号:
1603179
负责人:
Thomas LaBean
金额:
$35.99万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-15 至 2020-04-30

项目摘要

项目成果

Thomas LaBean的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PI: LaBean, Thom Proposal Number: 1603179Complex webs of cell signaling pathways make up cell-to-cell communication networks responsible for everything from homeostasis (maintaining equilibrium within our body), to wound healing, to development, and to immunity. These communication systems make use of direct contact between neighboring cells through specific nanometer-scale organization and presentation of cell surface receptors and ligands. This project will use a unique molecular engineering tool, termed DNA origami (or DNA folding), to determine how genes that control the production of proteins on the outer membranes of cells (major histocompatibility complex or MHC) interact with T-cell receptors (TCR). The interaction of the MHC and the TCR is the first step in the T-cell activation process, which impacts important biomedical issues in normal immune function, cancer, and autoimmune disease. Thus, the work in this proposal has the potential to enable a powerful toolkit for performing fundamental biological studies on receptor dynamics and developing therapies for immunological disorders. The goal of this project is to employ the rich palette of molecular engineering tools provided by structural DNA nanotechnology to specifically organize, orient, and present biologically active molecules to living cells in order to understand, facilitate, interrupt, and reprogram molecular interactions involved in cell signaling. Complex webs of cell signaling pathways make up the cell-to-cell communication networks responsible for everything from homeostasis, to wound healing, to development, and to immunity. These communication systems often make use of direct contact between neighboring cells via specific nanometer-scale organization and presentation of cell surface receptors and ligands they interact with. Specifically, the project will examine the spacing and multiplicity of presentation of the major histocompatibility complex (MHC) and its interaction with T-cell receptors (TCR) on the surfaces of living cells. The interaction of MHC and TCR is the first step in the complex biochemical cascade involving T-cell activation that impacts important biomedical issues in normal immune function, cancer, and autoimmune disease. DNA origami, a subset of DNA nanotechnology, will be assembled with designed architectures, patterns, and structural reinforcement in order to test a range of hypotheses in cell signaling science that would be very difficult or impossible to test by other, less programmable experimental methods. Novel basic science can now be pursued as well as testing of possible therapeutic strategies using DNA origami molecular assemblies displaying proteins, ligands, receptors, aptamers, small molecules, and other cell effectors. The combination of well-engineered experimental set-ups for probing individual cell-cell interactions allied with the programmable molecular recognition platforms of DNA-based nanostructures represents a new intellectual frontier with significant long-term potential in understanding biology and affecting human health. The program will lead to development of naturally biocompatible molecular organizers for a variety of biological and biomedical applications. Results from this study may provide major advances in understanding important events in T-cell activation and in cell-to-cell communications in general. Future extensions of this project could involve application of molecular materials and methods developed here toward other cell signaling pathways critical to understanding and improving human health. Graduate students will gain valuable opportunities for education and research training. The PI has consistently involved undergraduate, high school, and under-represented students in research programs and will redouble efforts to do so on this project
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/acs.bioconjchem.7b00288
发表时间: 2017-07-01
期刊: BIOCONJUGATE CHEMISTRY
影响因子: 4.7
作者: [Majikes, Jacob M., Ferraz, Lucas C. C., LaBean, Thomas H.]
通讯作者: LaBean, Thomas H.
EAGER: SHF: Three-Dimensional Electronics Integration Facilitated by Molecular Assembly
  • 批准号:
    1748459
  • 项目类别:
    Standard Grant
  • 资助金额:
    $22.23万
  • 财政年份:
    2017
  • 负责人:
    Thomas LaBean
  • 依托单位:
Collaborative Research: BMAT: Adapting Cas9 Protein from CRISPR as a Structural Unit for Molecular Assembly
  • 批准号:
    1709010
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $21.0万
  • 财政年份:
    2017
  • 负责人:
    Thomas LaBean
  • 依托单位:
IRES: Vertically Integrated Team for Structural DNA NanoTech in Denmark
  • 批准号:
    1559077
  • 项目类别:
    Standard Grant
  • 资助金额:
    $24.99万
  • 财政年份:
    2016
  • 负责人:
    Thomas LaBean
  • 依托单位:
Collaborative Research: Photonic and Electronic Devices Based on Self-Assembling DNA Templates
  • 批准号:
    1608847
  • 项目类别:
    Standard Grant
  • 资助金额:
    $21.01万
  • 财政年份:
    2016
  • 负责人:
    Thomas LaBean
  • 依托单位:
国内基金
海外基金
自供能传感阵列同步量化游离DNA与PSA实现前列腺癌的诊断和预后判断
  • 批准号:
    JCZRLH202601177
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
二氢杨梅素通过线粒体代谢重编程抑制DNA同源重组修复逆转口腔癌细胞放疗抵抗的机制研究
  • 批准号:
    2026JJ80500
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    阳帆
  • 依托单位:
乳酸通过ESM1-Akt-MDM2-p53通路调控卵巢癌DNA损伤和抗肿瘤免疫应答的分子机制研究
  • 批准号:
    2026JJ81975
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    肖娇
  • 依托单位:
淫羊藿苷通过TET2介导DNA去甲基化调控Hippo-YAP/TAZ通路逆转绝经后骨质疏松症成血管-成骨耦联失衡的机制研究